 "Dr Reddy's gains as USFDA completes inspection of Srikakulam SEZ unit")
Dr Reddy’s Laboratories was up 3% at Rs 2,722 on BSE in intra-day trade after the company on Friday announced that the US drug regulator has completed the audit of active pharmaceutical ingredients (APIs) manufacturing plant at Srikakulam special economic zone (SEZ) in Andhra Pradesh with no observations.
At 09:38 am; the stock was up 2.7% at Rs 2,712 against 0.18% decline in the S&P BSE Sensex. A combined 178,690 shares changed hands on the counter on BSE and NSE so far.
On March 22, 2017, the stock of Dr Reddy’s Laboratories hit an over two-year low of Rs 2,560 on BSE in intra-day trade after the drug maker on March 9 said the USFDA issued a Form 483 with 13 observations for the company’s formulation manufacturing facility at Duwada, Visakhapatnam.
At 09:38 am; the stock was up 2.7% at Rs 2,712 against 0.18% decline in the S&P BSE Sensex. A combined 178,690 shares changed hands on the counter on BSE and NSE so far.
On March 22, 2017, the stock of Dr Reddy’s Laboratories hit an over two-year low of Rs 2,560 on BSE in intra-day trade after the drug maker on March 9 said the USFDA issued a Form 483 with 13 observations for the company’s formulation manufacturing facility at Duwada, Visakhapatnam.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%